The test of time and editorial responsibility

Pigment Cell and Melanoma Research

Volumn 26, Issue 5, 2013, Pages 603-604

  Begley, C Glenn ^a  

^a TetraLogic Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RESEARCH; CELL COUNT; CELL GROWTH; CELL LINE; CLINICAL STUDY; EDITOR; HUMAN; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; LABORATORY; MEDICAL LITERATURE; NOTE; PRACTICE GUIDELINE; PUBLICATION; PUBLISHING; RESPONSIBILITY;

EDITORIAL POLICIES; GUIDELINES AS TOPIC; HUMANS; PERIODICALS AS TOPIC; REPRODUCIBILITY OF RESULTS;

EID: 84882901006     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12143     Document Type: Note

References (6)

1. Begley, C.G. (2013). Six red flags for suspect work. Nature 497, 433-434.
2. Begley, C.G., and Ellis, L.M. (2012). Drug development: raise standards for preclinical cancer research. Nature 483, 531-533.
3. Booth, B. (2011) http://lifescivc.com/2011/03/academic-bias-biotech-failures/
4. Bosenberg, M., Arnheiter, H., and Kelsh, R. (2013). The test of time. Pigment Cell Melanoma Res. 26, 152.
5. Announcement: reducing our irrepreducibility. Nature (2013). 496, 398.
6. Prinz, F., Schlange, T., and Asadullah, K.A. (2011). Believe it or not: how much can we rely on published data on potential drug targets? Nat. Rev. Drug Discovery 10, 712.